MUC20 and mantle cell lymphoma: In contrast, our previous study revealed that MUC20 attenuates PI (carfilzomib, CFZ) resistance by regulating proteasome capacity via the MET proto-oncogene receptor, receptor tyrosine kinase (MET) pathway in mantle cell lymphoma [10].